bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.04.28.538675

Sensorimotor Confidence for Tracking Eye Movements

Abstract

For successful interactions with the world, we often have to evaluate our own performance. Such metacognitive evaluations have been studied with perceptual decisions, but much less with respect to the evaluation of our own actions. While eye movements are one of the most frequent actions we perform, we are typically unaware of them. Here, we investigated if there is any evidence for metacognitive sensitivity for the accuracy of eye movements. Participants tracked a dot cloud as it followed an unpredictable sinusoidal trajectory for six seconds, and then reported if they thought their performance was better or worse than their average tracking performance. Our results show above chance identification of better tracking behavior across all trials and also for repeated attempts of the same target trajectories. While the sensitivity in discriminating performance between better and worse trials was stable across sessions, for their judgements participants relied more on performance in the final seconds of each trial. This behavior matched previous reports when judging the quality of hand movements, although overall metacognitive sensitivity for eye movements was significantly lower. Together, these results provide an additional piece of evidence for sensorimotor confidence, and open interesting questions about why it differs across actions and how it could be related to other instances of confidence. Statement of RelevanceIn everyday life, it is often critical to be able to evaluate the quality of our own cognitive decisions and actions. However, one of our most frequent actions often does not even reach our awareness: eye movements. We investigated whether observers were able to successfully judge the accuracy of their eye movements when tracking a cloud of dots that followed an unpredictable trajectory. We found that observers were able to distinguish good from bad trials, although sensitivity was lower compared to equivalent previous reports when judging the quality of hand movements. These results add an item to the growing list of our metacognitive abilities, but critically for eye movements that we are typically unaware of. They lead to important novel questions about why metacognitive abilities differ across decisions or different types of actions, and what the potential components of metacognitive abilities might be.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Goettker, A., Locke, S. M., Gegenfurtner, K. R., Mamassian, P.. 2023-04-28. Sensorimotor Confidence for Tracking Eye Movements. https://doi.org/10.1101/2023.04.28.538675

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗